Life sciences conference 2017

Seminar

November 9, 2017

The European life sciences team at Norton Rose Fulbright invites you to attend their annual life sciences conference in London.

Guest speakers include Oxford Nanopore Technologies and The Competition and Markets Authority (CMA).

We will bring together our own experts and industry experts to discuss a range of current topics, including: the legal ramifications of new generation technologies; European fund raising and M&A trends; and, the rapid growth of competition enforcement in the sector, both in the UK and internationally.

There will be two panel discussions during the event. Panelists include experts from industry and those with GC in-house and private practice experience from the EU and our international offices. 

There will be ample opportunities for questions and we will finish with a networking lunch.

Time

Topic

Speakers

08:45 – 09:15

Registration and networking breakfast

 

09:15 – 09:30

Welcome

Chair: Huw Evans, Partner (London), Head of Life Sciences EMEA

Session 1: New Generation Technologies

09:30- 09:50

Next generation sequencing – how Oxford Nanopore Technologies are shaping the landscape

Guest speaker: Martyn Andrews, Head of IP, Oxford Nanopore Technologies

09:50 – 10:50

Panel discussion: International perspectives on next generation technologies – a legal perspective including:

  • Effective protection of IP
  • Data privacy and GDPR
  • Regulatory aspects

Rick Robinson, Partner (Washington DC)

Pam Taak, Senior Associate (London)

Sven Jacobs, Associate (Frankfurt)

Guest speaker: Martyn Andrews, Head of IP, Oxford Nanopore Technologies

10:50 – 11:05

Coffee break

 

Session 2: Investment Trends

11:05 – 11:20

European fund raising and M&A trends

Heiko Bertelmann, Partner (Hamburg)

James Baillieu, Of Counsel (London)

Session 3: Competition and Pricing Issues

11:30 – 12:00

The approach of the CMA to life sciences cases:

  • How the CMA gathers information and decides on cases
  • What theories of harm interest the CMA (reverse payment settlements, excessive pricing, rebates, life cycle management)
  • How the CMA defines markets in life sciences contexts
  • Some current cases

Guest speaker: George Lusty, Project Director, Antitrust and Consumer Enforcement, Competition and Markets Authority 

12:00 – 12:30

Panel discussion: competition and pricing – regulation and enforcement trends globally

International perspectives from our in-house, private practice and industry experts

Robin Adelstein, Partner (New York)

Marta Giner, Partner (Paris)

Guest speaker: George Lusty, Project Director, Antitrust and Consumer Enforcement, Competition and Markets Authority 

12:30 – 12:35

Wrap up

Chair: Huw Evans, Partner (London), Head of Life Sciences EMEA

12:35 – 13:30

Networking lunch

 

Contacts

Huw Evans

Huw Evans

London
Pam Taak

Pam Taak

London